ASTRAZENECA PLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:22 am Unchanged |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 4.800% |
0 (Unchanged) |
Filing |
| 2021-04-07 5:37 pm Purchase |
2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 5.660% |
44,803 (New Position) |
Filing |